Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs

Journal of Cardiovascular Electrophysiology
Luc M Hondeghem

Abstract

Drug-induced QT prolongation has such a strong correlation with torsade de pointes (TdP) that it comes to serve as a surrogate for TdP. As a result, drugs that prolong QT by as little as a few ms, even without any evidence of TdP, may get dropped from development or blocked from approval. However, measurement of QT with ms accuracy may be impossible to achieve. Worse, some drugs that lengthen the QT interval are not only not proarrhythmic, they may even be antiarrhythmic; while some that shorten the QT can be strongly proarrhythmic. Indeed, proarrhythmia related to repolarization disturbances is caused by triangulation, reverse use dependence, instability, and dispersion (TRIaD). When TRIaD is present with QT prolongation it commonly yields TdP, but when TRIaD is combined with QT shortening it preferentially leads to VF instead. While TdP is lethal in less than 20% of instances, VF is much more morbid. Worse, available evidence suggests that there is more death from drug-induced fibrillation than TdP. Thus, QT prolongation alone is not very useful. Instead, the T-wave should be used in alternate ways: extraction of TRIaD.

References

Jan 1, 1975·Reviews of Physiology, Biochemistry and Pharmacology·G K Moe
Oct 28, 1975·Pflügers Archiv : European journal of physiology·B G KatzungA O Grant
Feb 4, 1998·Obesity Research·D NagyS B Heymsfield
Apr 16, 1998·Journal of Electrocardiology·C AntzelevitchS Sicouri
Apr 29, 1998·The American Journal of Cardiology·C M PrattA L Waldo
May 3, 2001·Journal of Cardiovascular Electrophysiology·M Malik
May 1, 2002·JAMA : the Journal of the American Medical Association·Robert J Temple, Martin H Himmel
Jul 13, 2002·Cardiac Electrophysiology Review·Markus Zabel, Marek Malik
Sep 5, 2002·British Journal of Clinical Pharmacology·Fabrizio De PontiNicola Montanaro
Aug 9, 2003·American Journal of Physiology. Heart and Circulatory Physiology·You-Wen QianWilliam T Clusin
Nov 5, 2003·Heart·Yee Guan Yap, A John Camm
Jan 13, 2004·Journal of Electrocardiology·Ronald D Berger
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
Apr 20, 2004·Journal of Cardiovascular Electrophysiology·Robert R FenichelUNKNOWN Independent Academic Task Force
May 19, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Alexander BurashnikovCharles Antzelevitch
Oct 7, 2004·Journal of the American College of Cardiology·Mark C HaigneyUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II investigators
Jan 22, 2005·Journal of Electrocardiology·Rashmi R Shah
Mar 15, 2005·European Journal of Pharmacology·Péter BiliczkiAndrás Varró
Apr 22, 2005·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Fabrice ExtramianaAntoine Leenhardt
Apr 22, 2005·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Wojciech Zareba, Antoni Bayes de Luna
Jul 5, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Rashmi R Shah, Luc M Hondeghem

❮ Previous
Next ❯

Citations

Dec 20, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Torsten ChristUrsula Ravens
Aug 31, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·L M HondeghemM Traebert
Nov 21, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Dan M RodenDawood Darbar
Jun 22, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Peter WeekeDan M Roden
May 19, 2010·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·A CorriasB Rodriguez
Nov 17, 2010·Pharmacological Reviews·Prince KannankerilDawood Darbar
Feb 10, 2010·Circulation·Barbara J DrewUNKNOWN American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Thomas MeyerElke Guenther
Apr 1, 2009·Expert Opinion on Drug Discovery·Malin Kb JonssonPeter Sartipy
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Pedro DoradoAdrián Llerena
Feb 22, 2011·Expert Opinion on Drug Safety·Leslie Citrome
Jul 4, 2009·Expert Opinion on Drug Metabolism & Toxicology·Emanuel RaschiMaurizio Recanatini
Dec 17, 2009·Toxicology and Applied Pharmacology·Nathaniel LeeMichael J Curtis
Mar 11, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Emanuel RaschiFabrizio De Ponti
Jul 27, 2007·Journal of Pharmacological and Toxicological Methods·Michael K Pugsley, Michael J Curtis
May 1, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Annukka LehtonenHeikki Swan
Dec 18, 2007·Journal of Cardiovascular Electrophysiology·Olivier XhaëtPhilippe Van de Borne
Mar 7, 2007·Journal of Cardiovascular Electrophysiology·Augustus O Grant, Joseph Tranquillo
May 10, 2007·Journal of Cardiovascular Electrophysiology·Luc M Hondeghem
Jan 9, 2014·Acta Anaesthesiologica Scandinavica·S BeitlandK Sunde
Nov 26, 2015·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Corrado GiulianiLaura Burattini
Feb 15, 2007·Expert Opinion on Therapeutic Targets·Harry J Witchel
Mar 3, 2009·Drug Metabolism and Pharmacokinetics·Antoine SoubretAnna Georgieva
Jun 13, 2012·The Journal of Toxicological Sciences·Anusak KijtawornratRobert L Hamlin
May 16, 2015·Biomaterials·Maria StancescuJames J Hickman
Jul 21, 2009·Journal of Pharmacological and Toxicological Methods·Liang GuoHeather Guthrie
Feb 27, 2010·Journal of the American College of Cardiology·Barbara J DrewUNKNOWN American College of Cardiology Foundation
Aug 23, 2016·Journal of Molecular and Cellular Cardiology·Pei-Chi YangColleen E Clancy
Oct 12, 2016·Journal of Child and Adolescent Psychopharmacology·Lan Chi VoLawrence Scahill
Apr 22, 2017·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Alan SugrueMichael J Ackerman
Jan 26, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyang-Ae LeeSung Joon Kim
Aug 5, 2008·American Journal of Physiology. Heart and Circulatory Physiology·K S DujardinL M Hondeghem
Dec 1, 2007·Journal of Cardiovascular Pharmacology·Luc M HondeghemJohn Camm
Oct 23, 2014·Clinical Pharmacology and Therapeutics·M C Haigney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.